Results of a feasibility study of I-124 girentuximab in metastatic clear cell renal cell carcinoma (m ccRCC).
Stephen Michael Keefe
Research Funding - Bristol-Myers Squibb
Mark Alan Rosen
No relevant relationships to disclose
Janelle Robinson
Research Funding - Bristol-Myers Squibb
Karen McGibney
Research Funding - Bristol-Myers Squibb
Amy Marshall
Research Funding - Bristol-Myers Squibb
Ronac Mamtani
No relevant relationships to disclose
David J. Vaughn
No relevant relationships to disclose
Peter J. O'Dwyer
No relevant relationships to disclose
Naomi B. Haas
No relevant relationships to disclose
Daniel A. Pryma
No relevant relationships to disclose